Gallagher, A. M., Setakis, E. ., Plumb, J. M., Clemens, A. ., & van Staa, T. P. (2011). Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients. Thromb Haemost. http://doi.org/10.1160/th11-05-0353
A. Clemens
First name
A.
Last name
Clemens
Gallagher, A. M., de Vries, F. ., Plumb, J. M., Hass, B. ., Clemens, A. ., & van Staa, T. P. (2012). Quality of INR control and outcomes following venous thromboembolism. Clin Appl Thromb Hemost. http://doi.org/10.1177/1076029611426139
Lee, S. ., Monz, B. U., Clemens, A. ., Brueckmann, M. ., & . Y. Lip, G. . (2012). Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the General Practice Research Database. BMJ Open. http://doi.org/10.1136/bmjopen-2012-001768
Gallagher, A. M., van Staa, T. P., Murray-Thomas, T. ., Schoof, N. ., Clemens, A. ., Ackermann, D. ., & Bartels, D. B. (2014). Population-based cohort study of warfarin-treated patients with atrial fibrillation: incidence of cardiovascular and bleeding outcomes. BMJ Open. http://doi.org/10.1136/bmjopen-2013-003839
Stolz, D. ., Kostikas, K. ., Loefroth, E. ., Fogel, R. ., Clemens, A. ., Gutzwiller, F. ., … Cao, H. . (2017). Gender differences in COPD exacerbations: Analysis from the CPRD database. Thorax.
Stolz, D. ., Kostikas, K. ., Loefroth, E. ., Fogel, R. ., Gutzwiller, F. S., Conti, V. ., … Clemens, A. . (2019). Differences in COPD exacerbation risk between women and men: analysis from the UK Clinical Practice Research Datalink data. Chest. http://doi.org/10.1016/j.chest.2019.04.107
Kostikas, K. ., Price, D. ., Gutzwiller, F. S., Jones, B. ., Loefroth, E. ., Clemens, A. ., … Cao, H. . (2020). Clinical Impact and Healthcare Resource Utilization Associated with Early versus Late COPD Diagnosis in Patients from UK CPRD Database. Int J Chron Obstruct Pulmon Dis. http://doi.org/10.2147/copd.s255414